Patent application number | Description | Published |
20080293730 | Tricyclo Substituted Amides - Compounds of Formula (I): (formula) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 11-27-2008 |
20080293741 | Tricyclo Substituted Amides as Glucokinase Modulators - Compounds of Formula (I): (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 11-27-2008 |
20090005391 | Tricyclo Substituted Amides - Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes. | 01-01-2009 |
20090221824 | ENANTIOSELECTIVE PROCESS - A process for the production of compounds comprising the enantioselective hydrogenation of 2-substituted acrylic acid derivatives. | 09-03-2009 |
20100093733 | AMIDE AND UREA DERIVATIVES FOR THE TREATMENT OF METABOLIC DISEASES - Compounds of formula (I): or pharmaceutically acceptable salts and esters thereof, are useful for the treatment of obesity, type II diabetes and the metabolic syndrome. | 04-15-2010 |
20100173886 | BICYCLIC ARYL AND HETEROARYL COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are opioid receptor modulators, e.g. mu-opioid receptor antagonists, neutral antagonists or inverse agonists, and are useful for the treatment of metabolic disorders including obesity. | 07-08-2010 |
20100286112 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS - The present invention is directed to therapeutic compounds which have dual activity as agonists of GPR119 and inhibitors of DPP-IV and are useful for the treatment of metabolic disorders including type II diabetes. | 11-11-2010 |
Patent application number | Description | Published |
20080261952 | Aryl Urea Derivatives for Treating Obesity - A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment. | 10-23-2008 |
20080269277 | Pyrrolopyridine-2-Carboxylic Acid Hydrazides - Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth. | 10-30-2008 |
20090023703 | Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase - Compounds represented by Formula (I): | 01-22-2009 |
20090203676 | G-protein Coupled Receptor Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 08-13-2009 |
20090221639 | Heterocyclic GPCR Agonists - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are agonists of GPR119 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes. | 09-03-2009 |
20090221644 | Gpcr Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 09-03-2009 |
20090325924 | GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. | 12-31-2009 |
20110178054 | Heterocyclic GPCR Agonists - Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity. | 07-21-2011 |
20110212939 | Heterocyclic GPCR Agonists - Compounds of formula (I) or pharmaceutically acceptable salts thereof, are GPCR (GPR119) agonists and are useful as for the treatment of diabetes and obesity. | 09-01-2011 |
20120077793 | Compounds for the Treatment of Metabolic Disorders - The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes. | 03-29-2012 |
20120172358 | GPCR Agonists - Compounds of formula (I): | 07-05-2012 |
20120214808 | Aryl Urea Derivatives for Treating Obesity - A method of treating a condition associated with the CB-1 receptor, in particular obesity, by administering an effective amount of an aryl urea CB-1 receptor modulating compound to a subject in need of such treatment. | 08-23-2012 |